NYSE:JNJ

Johnson & Johnson Stock News

Healthcare > Drug Manufacturers - General

Buy JNJ

*Your capital is at risk

$241.00

+1.92 (+0.80%)

At Close: Jun 24, 2026

IBM notifies J&J unit Janssen CarePath's customers of unauthorized data access

02:34pm, Wednesday, 06'th Sep 2023

IBM said on Wednesday it is notifying customers of Janssen CarePath, a Johnson & Johnson unit, of a "data incident" involving unauthorized access of personal information.

Call of the day: The health care trade

01:30pm, Wednesday, 06'th Sep 2023

CNBC's Halftime traders Steve Weiss, Liz Young, Joe Terranova, and Brian Belski discuss the call of the day: health care.

Cidara shares surge 18.5% as J&J unit Janssen takes lead on flu drug

09:36am, Wednesday, 06'th Sep 2023

Shares of Cidara Therapeutics soared 18.5% in early New York trading, buoyed by news that Janssen Pharmaceuticals, a subsidiary of healthcare giant Johnson & Johnson (NYSE:JNJ) Inc, is set to champion

J&J says drug combo contains lung cancer from spreading for longer duration

09:14am, Wednesday, 06'th Sep 2023

Johnson & Johnson said on Wednesday its combination drug helped increase the duration of no progress in a type of non small-cell lung cancer in patients.

7 Retirement Stocks That Every Long-Term Investor Should Own Now

08:27am, Wednesday, 06'th Sep 2023

Here's a look at the top long-term retirement stocks to buy now. Building a solid retirement portfolio is all about identifying companies that can withstand any storm in the market.

Is J&J a Buy After the Kenvue Separation?

06:00am, Wednesday, 06'th Sep 2023

J&J recently completed the spinoff of its consumer health business, letting go of star products that populate most of our medicine cabinets. But J&J's two other units, pharmaceuticals and medtech, act

3 Dow Stocks to Sell in September Before They Crash and Burn

06:21pm, Monday, 04'th Sep 2023

Many view the 30 stocks that comprise the Dow Jones Industrial Average as safe, solid “blue-chip” stocks that will never drop a great deal. For example, the business news company Kiplinger wrote:

4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032

09:45am, Sunday, 03'rd Sep 2023

Johnson & Johnson is a long-time healthcare leader with 61 straight years of dividend hikes. Visa and Mastercard have very little competition in their industry, and both still have growth potential.

Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?

07:30am, Saturday, 02'nd Sep 2023

Johnson & Johnson refreshed its financial guidance following its split from Kenvue. The healthcare behemoth offset most of the financial impact of the split because the exchange offer lowered its shar

Judge withdraws from Medicare drug price case after stock ownership is revealed

05:23pm, Friday, 01'st Sep 2023

Judge Thomas Rose of the U.S. District Court for the Southern District of Ohio withdrew from a case that could block Medicare's drug price negotiation program.

7 Cash Cow Stocks for Recession-Resilient Dividends

12:51pm, Friday, 01'st Sep 2023

The rally we've seen in previous weeks has given investors a breath of fresh air, but I believe volatility is likely to persist over the next few months. With the Federal Reserve committed to further

As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs

11:30am, Friday, 01'st Sep 2023

As Medicare's years-long drug-price negotiation process is being hotly debated and litigated, some states are plowing ahead with wide-ranging efforts to bring down costs for a potentially much broader

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by